TrialBMC musculoskeletal disorders2023

Twenty-four-month interim results from a prospective, single-arm clinical trial evaluating the performance and safety of cellular bone allograft in patients undergoing lumbar spinal fusion.

Daniel K Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.